Net profit of Sun Pharmaceutical Industries declined 36.22% to Rs 1988.53 crore in the quarter ended September 2026 as against Rs 3117.95 crore during the previous quarter ended September 2025. Sales rose 11.77% to Rs 16100.01 crore in the quarter ended September 2026 as against Rs 14405.22 crore during the previous quarter ended September 2025.